tiprankstipranks
Kyverna Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyKyverna Therapeutics participates in a conference call with JPMorgan
22d ago
After Kyverna data, Oppenheimer says Cartesian ‘can exploit’ CAR-T’s ‘baggage’
PremiumThe Fly
After Kyverna data, Oppenheimer says Cartesian ‘can exploit’ CAR-T’s ‘baggage’
23d ago
Kyverna: KYV-101 demonstrates ‘promising’ outcomes across multiple indications
PremiumThe Fly
Kyverna: KYV-101 demonstrates ‘promising’ outcomes across multiple indications
23d ago
PremiumCompany AnnouncementsKyverna Therapeutics Showcases CAR T-cell Therapy Progress at EULAR
24d ago
J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
1M ago
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
2M ago
Five new option listings and one option delisting on March 12th
PremiumThe FlyFive new option listings and one option delisting on March 12th
4M ago
Kyverna Therapeutics, Stanford University to evaluate KYV-101 in MS
PremiumThe Fly
Kyverna Therapeutics, Stanford University to evaluate KYV-101 in MS
4M ago
DoorDash, Lyft upgraded: Wall Street’s top analyst calls
PremiumThe Fly
DoorDash, Lyft upgraded: Wall Street’s top analyst calls
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100